2,3-dihydro-1-(2,2,2,-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzo
diazepines
    9.
    发明授权
    2,3-dihydro-1-(2,2,2,-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzo diazepines 失效
    2,3-二氢-1-(2,2,2-三氟乙基)-2-氧代-5-苯基-1H-1,4-苯并二氮杂

    公开(公告)号:US5658901A

    公开(公告)日:1997-08-19

    申请号:US516226

    申请日:1995-08-17

    摘要: This invention is concerned with novel compounds represented by structural formula I ##STR1## where X and Y are independently hydrogen, chloro, fluoro, bromo, iodo, or trifluoromethyl and n is 0, 1 or 2;R is hydrogen, fluoro, chloro, bromo, iodo, or trifluoromethyl, methyl, or methoxy; andthe racemates, mixtures of enantiomers, individual diastereomers or individual enantiomers with all isomeric forms and pharmaceutically acceptable salts, hydrates or crystal forms thereof, which are antiarrhythmic agents.

    摘要翻译: 本发明涉及由结构式I表示的新化合物,其中X和Y独立地是氢,氯,氟,溴,碘或三氟甲基,n是0,1或2; R为氢,氟,氯,溴,碘或三氟甲基,甲基或甲氧基; 以及具有所有异构体形式的外消旋物,对映体的混合物,单独的非对映异构体或单独的对映异构体,以及其抗心律失常药物的药学上可接受的盐,水合物或晶体形式。